NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Saturday, May 18, 2024 14:55

Description: MSD-AH
Telephone: 01908 685685 (Customer Support Centre)
Release 3.107
Nobivac® Solvent
 
Species: Cats, Dogs
Therapeutic indication: Immunological veterinary medical products: For dogs, For cats
Active ingredient: Vaccine Antigens
Product:Nobivac® Solvent
Product index: Nobivac® Solvent
Withdrawal notes: Not applicable.
Incorporating:
Qualitative and quantitative composition
Not applicable.
For full list of excipients see Pharmaceutical particulars section.
Pharmaceutical form
A clear colourless liquid solvent for parenteral use, consisting of sterile phosphate-buffered water presented in single 1 ml vials.
Clinical particulars
Target Species
Cats and dogs.
Indications for use
To reconstitute freeze dried small animal Nobivac vaccines which include instructions to be reconstituted with Nobivac Solvent.
Contraindications
Any contra-indications specified for the vaccine for which the Nobivac Solvent is used for reconstitution will apply.
Special warnings for each target species
None.
Special precautions for use
No special precautions are required for handling the solvent however any recommendations specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Sterile equipment should be used for administration. Avoid contamination of vaccine with traces of chemical sterilising agents. Do not use chemicals such as disinfectant or spirit to disinfect the skin prior to inoculation.
Operator warnings
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
After reconstitution: Any recommendations specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Adverse Reactions
Any adverse reaction specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Use during pregnancy or lactation
Any recommendations specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Interactions
Solvent should only be used for the reconstitution of Nobivac small animal vaccines which have specific instructions for use with Nobivac Solvent.
No information is available on the safety and efficacy when used with any other veterinary medicinal product. Any recommendations specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Amounts to be administered and administration route
The instructions supplied with the vaccine should be read carefully before using the Nobivac Solvent.
The contents of one vial (1 ml) of Nobivac Solvent should be transferred aseptically into the vial of freeze-dried vaccine immediately prior to use. Care should be taken to ensure that the freeze-dried powder plug has fully dissolved.
Overdose
Any recommendations specified for the vaccine for which Nobivac Solvent is used for reconstitution will apply.
Withdrawal period
Not applicable.
Pharmacological particulars
ATC Vet Code: Not applicable.
Pharmacotherapeutic group:
Not applicable. The diluent does not contain active ingredients.
Pharmaceutical particulars
Excipients
Potassium di-hydrogen phosphate
di-Sodium phosphate
Water for injections
Major incompatibilities
For use only with Intervet freeze-dried small animal vaccines which have specific instructions for reconstitution with Nobivac Solvent. Do not mix with any other veterinary medicinal product.
Shelf-life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Special precautions for storage
Do not store above 25°C. Do not freeze. Protect from light.
Immediate packaging
Clear, Glass Type I (Ph.Eur) single vials with halogenobutyl rubber stopper (Ph.Eur.) and aluminium crimp cap.
Pack size: Boxes with 10 x 1 ml or 50 x 1 ml vials.
Disposal
Solvent only: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
After reconstitution: Any recommendations specified for the vaccine for which Nobivac Solvent is used will apply.
Marketing Authorisation Holder (if different from distributor)
Marketing Authorisation Number
UK: Vm 01708/4368
Significant changes
Date of the first authorisation or date of renewal
28 October 2005
Date of revision of the text
29 November 2016
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
GTIN
GTIN description:--
GTIN:--